Semax vs N-Acetyl Semax Amidate
The parent-analogue comparison is one of the most common questions in Semax research contexts. N-Acetyl Semax Amidate ("NA-Semax") is chemically the same core heptapeptide as Semax, but with the N-terminal methionine acetylated and the C-terminal proline amidated. Both modifications block the aminopeptidase and carboxypeptidase attack pathways that clear the parent Semax rapidly from plasma. The result is a molecule with identical pharmacology but substantially better pharmacokinetics — and a much thinner evidence base to draw on.
At a glance
| Semax | N-Acetyl Semax | |
|---|---|---|
| Molecular structure | Free N-terminus + free C-terminus, MEHFPGP heptapeptide | N-acetyl protected + C-amidated MEHFPGP heptapeptide |
| Sequence | Met-Glu-His-Phe-Pro-Gly-Pro | Ac-Met-Glu-His-Phe-Pro-Gly-Pro-NH₂ |
| Molecular weight | 813.93 g/mol | ~869 g/mol (with terminal modifications) |
| Plasma half-life | Minutes (parent peptide) | Several-fold longer (approximately 3–4× parent) |
| Pharmacodynamic action | 24h+ effect on BDNF/NGF from single dose | Longer, more sustained BDNF/NGF exposure per dose |
| Typical dosing frequency | 2–3× daily in Russian protocols | 1–2× daily in published research |
| Evidence base | Deep — Russian clinical use since 1994, multiple RCTs | Sparser — analogue-specific data is thinner |
| Clinical approval | Approved in Russia for cerebrovascular indications | No clinical approval; research chemical |
| Route | Intranasal (primary) | Intranasal (primary) |
| Evidence tier | A | C (limited human data specific to analogue) |
| UK status | Research chemical | Research chemical |
The engineering rationale
Why the terminal modifications matter
Semax is efficiently degraded in plasma by two enzyme families. Aminopeptidases attack the free α-amine at the N-terminus, sequentially removing amino acids from the front of the peptide. Carboxypeptidases attack the free carboxylate at the C-terminus, sequentially removing amino acids from the back. Both attacks together give parent Semax a plasma half-life of only minutes.
The N-terminal acetyl group and C-terminal amide of N-Acetyl Semax Amidate block both attacks. The acetyl group removes the free α-amine that aminopeptidases require as a substrate; the amide removes the free carboxylate that carboxypeptidases require. The internal peptide bonds remain susceptible to endopeptidase cleavage, but this is a slower and rate-limited process rather than the rapid terminal trimming that dominates parent Semax clearance.
The result is a molecule with identical receptor pharmacology (the terminal residues don't interact with the mechanism) but substantially longer duration of action per dose. In practical research terms, that means fewer daily doses for equivalent pharmacodynamic effect and better adherence in long protocols.
When to choose which